Increase in soluble CD138 in bronchoalveolar lavage fluid of multicentric Castleman's disease

Masaru Hasegawa, Tomoko Betsuyaku, Nobuya Yoshida, Yasuyuki Nasuhara, Ichiro Kinoshita, Satoshi Ohta, Tomoo Itoh, Pyong Woo Park, Masaharu Nishimura

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Multicentric Castleman's disease (MCD) is a rare and often incurable lymphoproliferative disorder. It is typically a systemic illness, but occasionally manifests primarily as a pulmonary parenchymal disease with massive infiltration of CD138 (syndecan-1)-positive plasma cells. This is the first report to demonstrate a marked elevation of soluble CD138, despite the absence of plasma cells, in BAL fluid in an MCD patient with pulmonary involvement. This finding suggests that the quantitative measurement of soluble CD138 in BAL fluid may reflect plasma cell infiltration and disease activity in the lungs of patients with MCD.

Original languageEnglish
Pages (from-to)140-143
Number of pages4
JournalRespirology
Volume12
Issue number1
DOIs
Publication statusPublished - 2007 Jan
Externally publishedYes

Fingerprint

Bronchoalveolar Lavage Fluid
Plasma Cells
Dimercaprol
Syndecan-1
Lung
Lymphoproliferative Disorders
Lung Diseases
Multi-centric Castleman's Disease

Keywords

  • BAL
  • IL-6
  • Multicentric Castleman's disease
  • Syndecan

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Hasegawa, M., Betsuyaku, T., Yoshida, N., Nasuhara, Y., Kinoshita, I., Ohta, S., ... Nishimura, M. (2007). Increase in soluble CD138 in bronchoalveolar lavage fluid of multicentric Castleman's disease. Respirology, 12(1), 140-143. https://doi.org/10.1111/j.1440-1843.2006.00967.x

Increase in soluble CD138 in bronchoalveolar lavage fluid of multicentric Castleman's disease. / Hasegawa, Masaru; Betsuyaku, Tomoko; Yoshida, Nobuya; Nasuhara, Yasuyuki; Kinoshita, Ichiro; Ohta, Satoshi; Itoh, Tomoo; Park, Pyong Woo; Nishimura, Masaharu.

In: Respirology, Vol. 12, No. 1, 01.2007, p. 140-143.

Research output: Contribution to journalArticle

Hasegawa, M, Betsuyaku, T, Yoshida, N, Nasuhara, Y, Kinoshita, I, Ohta, S, Itoh, T, Park, PW & Nishimura, M 2007, 'Increase in soluble CD138 in bronchoalveolar lavage fluid of multicentric Castleman's disease', Respirology, vol. 12, no. 1, pp. 140-143. https://doi.org/10.1111/j.1440-1843.2006.00967.x
Hasegawa M, Betsuyaku T, Yoshida N, Nasuhara Y, Kinoshita I, Ohta S et al. Increase in soluble CD138 in bronchoalveolar lavage fluid of multicentric Castleman's disease. Respirology. 2007 Jan;12(1):140-143. https://doi.org/10.1111/j.1440-1843.2006.00967.x
Hasegawa, Masaru ; Betsuyaku, Tomoko ; Yoshida, Nobuya ; Nasuhara, Yasuyuki ; Kinoshita, Ichiro ; Ohta, Satoshi ; Itoh, Tomoo ; Park, Pyong Woo ; Nishimura, Masaharu. / Increase in soluble CD138 in bronchoalveolar lavage fluid of multicentric Castleman's disease. In: Respirology. 2007 ; Vol. 12, No. 1. pp. 140-143.
@article{f6bf8c2e25e74d9e8d2a3aabc2eda85d,
title = "Increase in soluble CD138 in bronchoalveolar lavage fluid of multicentric Castleman's disease",
abstract = "Multicentric Castleman's disease (MCD) is a rare and often incurable lymphoproliferative disorder. It is typically a systemic illness, but occasionally manifests primarily as a pulmonary parenchymal disease with massive infiltration of CD138 (syndecan-1)-positive plasma cells. This is the first report to demonstrate a marked elevation of soluble CD138, despite the absence of plasma cells, in BAL fluid in an MCD patient with pulmonary involvement. This finding suggests that the quantitative measurement of soluble CD138 in BAL fluid may reflect plasma cell infiltration and disease activity in the lungs of patients with MCD.",
keywords = "BAL, IL-6, Multicentric Castleman's disease, Syndecan",
author = "Masaru Hasegawa and Tomoko Betsuyaku and Nobuya Yoshida and Yasuyuki Nasuhara and Ichiro Kinoshita and Satoshi Ohta and Tomoo Itoh and Park, {Pyong Woo} and Masaharu Nishimura",
year = "2007",
month = "1",
doi = "10.1111/j.1440-1843.2006.00967.x",
language = "English",
volume = "12",
pages = "140--143",
journal = "Respirology",
issn = "1323-7799",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Increase in soluble CD138 in bronchoalveolar lavage fluid of multicentric Castleman's disease

AU - Hasegawa, Masaru

AU - Betsuyaku, Tomoko

AU - Yoshida, Nobuya

AU - Nasuhara, Yasuyuki

AU - Kinoshita, Ichiro

AU - Ohta, Satoshi

AU - Itoh, Tomoo

AU - Park, Pyong Woo

AU - Nishimura, Masaharu

PY - 2007/1

Y1 - 2007/1

N2 - Multicentric Castleman's disease (MCD) is a rare and often incurable lymphoproliferative disorder. It is typically a systemic illness, but occasionally manifests primarily as a pulmonary parenchymal disease with massive infiltration of CD138 (syndecan-1)-positive plasma cells. This is the first report to demonstrate a marked elevation of soluble CD138, despite the absence of plasma cells, in BAL fluid in an MCD patient with pulmonary involvement. This finding suggests that the quantitative measurement of soluble CD138 in BAL fluid may reflect plasma cell infiltration and disease activity in the lungs of patients with MCD.

AB - Multicentric Castleman's disease (MCD) is a rare and often incurable lymphoproliferative disorder. It is typically a systemic illness, but occasionally manifests primarily as a pulmonary parenchymal disease with massive infiltration of CD138 (syndecan-1)-positive plasma cells. This is the first report to demonstrate a marked elevation of soluble CD138, despite the absence of plasma cells, in BAL fluid in an MCD patient with pulmonary involvement. This finding suggests that the quantitative measurement of soluble CD138 in BAL fluid may reflect plasma cell infiltration and disease activity in the lungs of patients with MCD.

KW - BAL

KW - IL-6

KW - Multicentric Castleman's disease

KW - Syndecan

UR - http://www.scopus.com/inward/record.url?scp=33845691457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845691457&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1843.2006.00967.x

DO - 10.1111/j.1440-1843.2006.00967.x

M3 - Article

C2 - 17207040

AN - SCOPUS:33845691457

VL - 12

SP - 140

EP - 143

JO - Respirology

JF - Respirology

SN - 1323-7799

IS - 1

ER -